Clinical Trial Results

Showing: All studies [change]
Condition: Lupus Location: Lee's Summit, Missouri 6 trials found
New Search
Filter
Trial Phase
What's the difference?
Study Type
What's the difference?
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Avondale, Arizona +4 more
RECRUITING
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
PHASE4INTERVENTIONAL La Mesa, California +4 more
RECRUITING
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
PHASE1, PHASE2INTERVENTIONAL Orange, California +4 more
RECRUITING
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type